Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 41 for prostate cancer

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Study Of Zanzalintinib In Combination With Immuno-Oncology Agents In Participants With Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Clinical Study Of KTX-2001 In Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

    Rochester, MN

  3. A Study Of SYNC-T Therapy SV-102 In Participants With Metastatic Castration-Resistant Prostate Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  4. Trial Of Neoadjuvant Enoblituzumab Vs SOC In Men With High-Risk Localized Prostate Cancer

    Rochester, MN

  5. A Phase I Study Of [225Ac]-AZD2284 In Patients With Metastatic Castration-Resistant Prostate Cancer

    Rochester, MN

  6. Schedule De-Escalation Of 177Lu-PSMA-617 For The Treatment Of Metastatic Castrate Resistant Prostate Cancer

    Rochester, MN

  7. Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance Of Intermediate Risk Prostate Cancer

    Rochester, MN

  8. A Study Of GSK5458514 Administered Alone Or In Combination With Other Anti-Cancer Agents In Participants With Prostate Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. Positron Emission Tomography Using 64Cu-SAR-bisPSMA In Participants With High-risk Prostate Cancer Prior To Radical Prostatectomy

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. Evaluating Changes In Quality Of Life After Near Margin-less Adaptive Radiation Therapy Compared To Standard Stereotactic Ablative Body Radiotherapy In Localized Prostate Cancer

    Albert Lea, MN, Eau Claire, WI, La Crosse, WI, Mankato, MN, Rochester, MN

.

Mayo Clinic Footer